NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Nearly 2 billion of the world’s population living in low- and middle-income countries still do not have access to basic medicines, according to the World Health Organization. But COVID-19 can offer a valuable lesson in how the global health community can jointly improve access to life-saving medicines for the most underserved populations.

Innovative medicines and treatments emerging from research and development pipelines are revolutionizing health in various areas, yet many people still lack access to well-known essential medicines. In the context of the current pandemic, we have the opportunity to not only fast-track access to new products, but also ensure everyone, everywhere, can afford them.

On Thursday, Sept. 23, Devex will host an ecosystem event on the sidelines of the 76th annual United Nations General Assembly in partnership with Gilead, exploring how new access models can allow for more coordinated and targeted approaches. Discussions will draw on lessons learned from the pandemic and beyond on how to best support more resilient health systems, and ultimately ensure progress on universal health coverage and the health-related Sustainable Development Goals.

This event will include live captioning.

Time: 12 p.m. ET | 6 p.m. CET